{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:49:23Z","timestamp":1776854963636,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.brachy.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T07:37:45Z","timestamp":1695454665000},"page":"800-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Viability of focal dose escalation to prostate cancer intraprostatic lesions using HDR prostate brachytherapy"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9187-2618","authenticated-orcid":false,"given":"Joel","family":"Poder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Radvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-2791","authenticated-orcid":false,"given":"Andrew","family":"Howie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-1125","authenticated-orcid":false,"given":"Farshad","family":"Kasraei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annaleise","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Haworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2023.09.001_bib0001","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2021.02.008","article-title":"Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy","volume":"159","author":"Zelefsky","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210683","article-title":"MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial","volume":"95","author":"Zapatero","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0004","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2007.03.065","article-title":"Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence","volume":"69","author":"Pucar","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.09.001_bib0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.radonc.2019.09.011","article-title":"MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): results from a phase II clinical trial","volume":"141","author":"Alayed","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0006","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2020.03.015","article-title":"Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer","volume":"147","author":"Draulans","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0007","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijrobp.2021.10.137","article-title":"SABR for high-risk prostate cancer: a prospective multilevel MRI-based dose escalation trial","volume":"113","author":"Hannan","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.09.001_bib0008","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.brachy.2014.05.006","article-title":"Ultrasound-planned high-dose-rate prostate brachytherapy: dose painting to the dominant intraprostatic lesion","volume":"13","author":"Crook","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.09.001_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.radonc.2016.02.004","article-title":"Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial","volume":"119","author":"Gomez-Iturriaga","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.brachy.2016.09.004","article-title":"Image-guided high-dose-rate brachytherapy boost to the dominant intraprostatic lesion using multiparametric magnetic resonance imaging including spectroscopy: results of a prospective study","volume":"15","author":"Vigneault","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.09.001_bib0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5114\/jcb.2018.76881","article-title":"Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy","volume":"10","author":"Chapman","year":"2018","journal-title":"J Contemp Brachy"},{"key":"10.1016\/j.brachy.2023.09.001_bib0012","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2018.0587","article-title":"Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9-10 prostate cancer","volume":"319","author":"Kishan","year":"2018","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.brachy.2023.09.001_bib0013","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190089","article-title":"Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy","volume":"92","author":"Wang","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0014","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2020.05.029","article-title":"Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: dosimetry, toxicity and health related quality of life","volume":"149","author":"Sanmamed","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.radonc.2020.09.007","article-title":"Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: outcomes from two clinical trials with and without an MRI-guided boost","volume":"154","author":"Alayed","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0016","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2021.03.018","article-title":"Single dose high-dose-rate brachytherapy with focal dose escalation for prostate cancer: mature results of a phase 2 clinical trial","volume":"159","author":"Armstrong","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0017","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5114\/jcb.2022.120035","article-title":"Dose differentiated high-dose-rate prostate brachytherapy: a feasibility assessment of MRI-guided dose escalation to dominant intra-prostatic lesions","volume":"14","author":"Luminais","year":"2022","journal-title":"J Contemp Brachy"},{"key":"10.1016\/j.brachy.2023.09.001_bib0018","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijrobp.2022.11.005","article-title":"An updated analysis of the survival endpoints of ASCENDE-RT","volume":"115","author":"Oh","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.09.001_bib0019","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2018.08.006","article-title":"Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapy","volume":"18","author":"Shaaer","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.09.001_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.brachy.2020.06.014","article-title":"Dosimetric evaluation of MRI-to-ultrasound automated image registration algorithms for prostate brachytherapy","volume":"19","author":"Shaaer","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.09.001_bib0021","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/nbm.3218","article-title":"MR elastography of prostate cancer: quantitative comparison with histopathology and repeatability of methods","volume":"28","author":"Sahebjavaher","year":"2015","journal-title":"NMR Biomed"},{"key":"10.1016\/j.brachy.2023.09.001_bib0022","first-page":"1","article-title":"Evaluation of an automatic segmentation algorithm for definition of head and neck organs at risk","volume":"9","author":"Thomson","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0023","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1002\/mp.12256","article-title":"Use of image registration and fusion algorithms and techniques in radiotherapy: report of the AAPM Radiation Therapy Committee Task Group No. 132","volume":"44","author":"Brock","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.09.001_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2020.101845","article-title":"Biomechanically constrained non-rigid MR-TRUS prostate registration using deep learning based 3D point cloud matching","volume":"67","author":"Fu","year":"2021","journal-title":"Med Image Anal"},{"key":"10.1016\/j.brachy.2023.09.001_bib0025","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/acm2.13292","article-title":"MRI-TRUS registration methodology for TRUS-guided HDR prostate brachytherapy","volume":"22","author":"McGeachy","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.brachy.2023.09.001_bib0026","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1109\/TNS.2011.2136387","article-title":"Development of a PET-transrectal ultrasound prostate imaging system","volume":"58","author":"Huber","year":"2011","journal-title":"IEEE Trans Nucl Sci"},{"key":"10.1016\/j.brachy.2023.09.001_bib0027","series-title":"Med Imaging 2018: Image-Guided Procedures, Robotic Interventions, and Modeling: SPIE","first-page":"706","article-title":"CT-ultrasound deformable registration for PET-determined prostate brachytherapy","author":"Lee","year":"2018"},{"key":"10.1016\/j.brachy.2023.09.001_bib0028","series-title":"Med Imaging 2019: Image-Guided Procedures, Robotic Interventions, and Modeling: SPIE","first-page":"383","article-title":"A deformable multimodal image registration using PET\/CT and TRUS for intraoperative focal prostate brachytherapy","author":"Sultana","year":"2019"},{"key":"10.1016\/j.brachy.2023.09.001_bib0029","doi-asserted-by":"crossref","DOI":"10.1117\/1.JMI.6.3.035003","article-title":"Deformable registration of PET\/CT and ultrasound for disease-targeted focal prostate brachytherapy","volume":"6","author":"Sultana","year":"2019","journal-title":"J Med Imaging"},{"key":"10.1016\/j.brachy.2023.09.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20201174","article-title":"Prostate cancer GTV delineation with biparametric MRI and 68Ga-PSMA-PET: comparison of expert contours and semi-automated methods","volume":"94","author":"Hearn","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2023.09.001_bib0031","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7150\/thno.16638","article-title":"Comparison of 68Ga-HBED-CC PSMA-PET\/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology","volume":"7","author":"Zamboglou","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.brachy.2023.09.001_bib0032","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.brachy.2022.01.009","article-title":"Targeting prostate lesions on multiparametric MRI with HDR brachytherapy: optimal planning margins determined using whole-mount digital histology","volume":"21","author":"Smith","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.09.001_bib0033","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.brachy.2018.05.005","article-title":"A risk-based approach to development of ultrasound-based high-dose-rate prostate brachytherapy quality management","volume":"17","author":"Poder","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.09.001_bib0034","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2015.12.022","article-title":"In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: comparison with planned and reconstructed doses","volume":"118","author":"Carrara","year":"2016","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:20:17Z","timestamp":1761531617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472123016264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1538472123016264"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.09.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viability of focal dose escalation to prostate cancer intraprostatic lesions using HDR prostate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. on behalf of American Brachytherapy Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}